您的位置: 首页 > 农业专利 > 详情页

percutaneous absorption preparation containing rivastigmine
专利权人:
SAMYANG BIOPHARMACEUTICALS CORPORATION;TRANSDERM INC.
发明人:
HEE-SOOK KIM,HYUN-SUK YU,HYUN-WOO KIM,YOUNG-MOO LEE
申请号:
BR112013016266
公开号:
BR112013016266A2
申请日:
2011.12.22
申请国别(地区):
BR
年份:
2018
代理人:
摘要:
Disclosed is a percutaneous absorption preparation for treatment of dementia that comprises rivastigmine or its pharmaceutically acceptable salt as an active ingredient, a styrene-isoprene-styrene block copolymer, a tackifier resin, and a plasticizer, which preparation contains a small amount of rivastigmine but allows a sufficient amount of the active ingredient penetrated into the skin to achieve an effective treatment of dementia.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充